478 related articles for article (PubMed ID: 14576095)
21. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
Shah A; Mond J; Walsh S
Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
[TBL] [Abstract][Full Text] [Related]
22.
Delpech G; Ceci M; Lissarrague S; García Allende L; Baldaccini B; Sparo M
Biofouling; 2020 Mar; 36(3):266-275. PubMed ID: 32338055
[No Abstract] [Full Text] [Related]
23. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
[TBL] [Abstract][Full Text] [Related]
24. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
Nair S; Poonacha N; Desai S; Hiremath D; Tuppad D; Mohan T; Chikkamadaiah R; Durgaiah M; Kumar S; Channabasappa S; Vipra A; Sharma U
J Med Microbiol; 2018 Mar; 67(3):296-307. PubMed ID: 29458674
[TBL] [Abstract][Full Text] [Related]
25. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
[TBL] [Abstract][Full Text] [Related]
26. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
Placencia FX; Kong L; Weisman LE
Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
[TBL] [Abstract][Full Text] [Related]
27. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Singh R; Ray P; Das A; Sharma M
Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203
[TBL] [Abstract][Full Text] [Related]
28. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Singh R; Ray P; Das A; Sharma M
J Antimicrob Chemother; 2010 Sep; 65(9):1955-8. PubMed ID: 20615927
[TBL] [Abstract][Full Text] [Related]
29. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
30. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
31. Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci.
Saising J; Ongsakul M; Voravuthikunchai SP
J Med Microbiol; 2011 Dec; 60(Pt 12):1793-1800. PubMed ID: 21816945
[TBL] [Abstract][Full Text] [Related]
32. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis.
Ceotto-Vigoder H; Marques SL; Santos IN; Alves MD; Barrias ES; Potter A; Alviano DS; Bastos MC
J Appl Microbiol; 2016 Jul; 121(1):101-14. PubMed ID: 26999597
[TBL] [Abstract][Full Text] [Related]
33. Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus.
Vandecandelaere I; Van Nieuwerburgh F; Deforce D; Coenye T
PLoS One; 2017; 12(3):e0172700. PubMed ID: 28263995
[TBL] [Abstract][Full Text] [Related]
34. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Nodzo SR; Boyle KK; Frisch NB
J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
36. In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Pettit RK; Weber CA; Lawrence SB; Pettit GR; Kean MJ; Cage GD
J Med Microbiol; 2009 Sep; 58(Pt 9):1203-1206. PubMed ID: 19528175
[TBL] [Abstract][Full Text] [Related]
37. Lysostaphin: an antistaphylococcal agent.
Kumar JK
Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
[TBL] [Abstract][Full Text] [Related]
38. Triton X-100 alters the resistance level of methicillin-resistant Staphylococcus aureus to oxacillin.
Komatsuzawa H; Sugai M; Shirai C; Suzuki J; Hiramatsu K; Suginaka H
FEMS Microbiol Lett; 1995 Dec; 134(2-3):209-12. PubMed ID: 8586269
[TBL] [Abstract][Full Text] [Related]
39. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.
Mohamed MF; Hamed MI; Panitch A; Seleem MN
Antimicrob Agents Chemother; 2014 Jul; 58(7):4113-22. PubMed ID: 24798285
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms.
Sivaranjani M; Prakash M; Gowrishankar S; Rathna J; Pandian SK; Ravi AV
Appl Microbiol Biotechnol; 2017 Apr; 101(8):3349-3359. PubMed ID: 28343241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
